Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-046082

Chief Financial Officer sold 20,000 shares at an average $38.68 ($773,619)

  • Chief Financial Officer acquired 20,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-06 Exercise or conversion : show line 1 in the form +10,000 $6.55 $65,500 31,604 D
2021-07-06 Sale : show line 2 in the form −10,000 $38.83 $388,300 21,604 D
2021-07-07 Exercise or conversion : show line 3 in the form +10,000 $6.55 $65,500 31,604 D
2021-07-07 Sale : show line 4 in the form −6,486 $38.17 $247,571 25,118 D
2021-07-07 Sale : show line 5 in the form −3,514 $39.20 $137,749 21,604 D
Open-market sales · 20,000 sh · avg $38.68 · $773,619

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-07-06 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −10,000 100,000 D
2021-07-07 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −10,000 90,000 D
Loading xslF345X03/doc4.xml…